[Use of vinblastine in Hodgkin's disease].
D000380:Agranulocytosis / Q000139:chemically induced; D001341:Autonomic Nervous System / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D005069:Evaluation Studies as Topic; D006261:Headache / Q000139:chemically induced; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D007970:Leukopenia / Q000139:chemically induced; D013997:Time Factors; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D014747:Vinblastine
Zastosowanie preparatu Vinblastin w leczeniu ziarnicy złośliwej